Abstract Background Each myositis-specific autoantibody (MSA) tends to have a distinct clinical presentation. Coexistence of MSAs do not commonly occur. If they do. it is unknown if there is an overlap of clinical features or prognostic implications. https://www.lightemupsequences.com/